Study of STAT3 Expression in Different Phases of Patients with Chronic Myeloid Leukemia
Background and Aim: Chronic myeloid leukemia(CML) is a clonal myeloproliferative disease, characterized by BCR/ABL translocation. Using tyrosine kinase inhibitors such as Imatinib, treatment for this disease has progressed remarkably. However, resistance to tyrosine kinase inhibitor is a major obsta...
Saved in:
Main Authors: | Peyman Yousefi (Author), Shahrbano Rostami (Author), Nasrin Alizadeh Ghandfurosh (Author), Saeed Mohammadi (Author), Mohsen Nikbakht (Author), Laya Ghadyaninejhad (Author), Bahram Chahardouli (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines
by: Mohammadi Kian M, et al.
Published: (2020) -
Myeloid Leukemia
Published: (2018) -
Two Cases of Chronic Myeloid Leukemia in Lymphoid Blast Phase Presented as Philadelphia-Positive Acute Lymphoblastic Leukemia
by: Tae Hoon Lee, et al.
Published: (2023) -
Myeloid cell leukemia-1 protein expression and myeloid cell leukemia-1 gene amplification in non small cell lung cancer
by: Tony El Jabbour, et al.
Published: (2018) -
WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy
by: Hossein Mehralizadeh, et al.
Published: (2021)